Corpus Intelligence IC Memo — OVERLAND PARK REGIONAL MED CTR 2026-04-26 04:05 UTC
IC Memo — OVERLAND PARK REGIONAL MED CTR
Investment Committee Memorandum | KS | 271 beds | Grade C | EBITDA uplift $33.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OVERLAND PARK REGIONAL MED CTR

CCN 170176 | nan, KS | 271 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OVERLAND PARK REGIONAL MED CTR is a 271-bed suburban community hospital in nan, KS with $452.2M in net patient revenue and a 35.9% operating margin. The hospital serves a payer mix of 19.2% Medicare, 4.9% Medicaid, and 75.9% commercial.

Thesis: Platform Growth. Our ML models identify $33.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 35.9% to 43.3% (+736bps).

Net Revenue HCRIS$452.2M
Current EBITDA COMPUTED$162.4M
Operating Margin COMPUTED35.9%
Occupancy HCRIS75.0%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS15.5%
Distress Probability ML40.5%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
9
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of 35.9% places it above the state median. Among 9 size-comparable peers (136-542 beds), the median margin is -12.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (136-542), prioritizing same-state peers. 9 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OVERLAND PARK REGIONAL MED CTR (Target)KS271$452.2M35.9%
STORMONT-VAIL REGIONAL HEALTH KS438$825.0M-2.0%
ADVENTHEALTH SHAWNEE MISSIONKS317$555.8M0.1%
AM 1 MENORAH MEDICAL CENTERKS137$289.4M8.5%
ST.FRANCIS HEALTH CENTERKS228$276.6M-13.7%
OLATHE MEDICAL CENTERKS237$272.8M-6.5%
SALINA REGIONAL HEALTH CENTERKS177$226.7M-39.5%
HAYS MEDICAL CENTER INC.KS136$215.1M-12.3%
HUTCHINSON REGIONAL MEDICAL CEKS147$132.3M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $33.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$9.5M+210bp18mo
Cost to Collect4.5%2.5%$9.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$9.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.5M+122bp9mo
Clean Claim Rate88.0%96.0%$289K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$9.5M
Cost to Collect
$9.0M
Denial Rate Reduction
$9.0M
A/R Days Reduction
$5.5M
Clean Claim Rate
$289K
Total EBITDA Uplift$33.3M
Current EBITDA$162.4M
+ RCM Uplift+$33.3M
Pro Forma EBITDA$195.6M
Current Margin35.9%
Pro Forma Margin43.3%
WC Released (1x)$17.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$249.8M$1.40B5.62x41.2%
Base (11x exit)10.0x11.0x$249.8M$1.63B6.51x45.4%
Bull Case9.0x11.0x$224.8M$1.82B8.08x51.9%
Bull (12x exit)9.0x12.0x$224.8M$2.05B9.11x55.6%
Bear Case11.0x10.0x$274.8M$1.16B4.21x33.3%
Bear (11x exit)11.0x11.0x$274.8M$1.36B4.95x37.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 9 hospitals with 136-542 beds
  • Same-state prioritization (n=10)
  • Comp margins: P25=-15.3% / P50=-12.3% / P75=-2.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.